Latest stories on VVOS
8-K/A - Vivos Therapeutics, Inc. (VVOS) files 8-K
SEC 8-K50 · neutralgeneral
Vivos Therapeutics Announces Material Debt Reduction
Business Insider63 · neutralgeneral
Vivos Therapeutics Announces Material Debt Reduction
GlobeNewswire67 · bullishgeneral
Vivos Therapeutics, Inc. (VVOS) files 8-K
SEC 8-K50 · neutralgeneral
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference
StockTitan56 · neutralgeneral
Vivos Therapeutics, SPCVA to launch regional sleep testing and treatment center
The Fly56 · neutralproduct/pr
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
Business Insider63 · neutralproduct/pr
Vivos Therapeutics reports new patient referrals at Nevada Sleep & Airway
The Fly56 · neutralgeneral
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
Business Insider63 · neutralproduct/pr
Vivos Therapeutics, Inc. (VVOS) files 8-K
SEC 8-K50 · neutralgeneral
Vivos Therapeutics opens sleep testing, treatment facility in Nevada
The Fly63 · neutralproduct/pr
Vivos Therapeutics shares slide after Q2 revenue falls short of forecasts
InvestorsHub38 · neutralearnings
Vivos Therapeutics GAAP EPS of -$0.31 misses by $0.01, revenue of $5.15M misses by $0.99M
Seeking Alpha34 · bearishearnings
Vivos Therapeutics, Inc. (VVOS) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update
GlobeNewswire56 · neutralearnings
Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update
StockTitan50 · neutralgeneral
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
GlobeNewswire50 · neutralgeneral
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
Business Insider50 · neutralgeneral
Vivos Therapeutics Strengthens IP for Sleep Apnea Devices
TipRanks63 · neutralproduct/pr
Vivos Therapeutics, Inc. (VVOS) files 8-K
SEC 8-K50 · neutralgeneral
VVOS Targets $9 Million Yearly Value With AI-Driven Expansion in Healthcare Operations
August 11, 2026
MarketChameleon67 · bullishproduct/pr
Vivos Therapeutics Expands Strategic Engagement With Greenway Health
The Fly56 · neutralproduct/pr
Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations
Business Insider63 · neutralproduct/pr